2,793
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Recent successes and future predictions on drug repurposing for rare diseases

 

Abstract

Some rare disease treatments come from drug repurposing. The biopharma industry focuses on commercial rare disease drug repurposing, and disease-specific non-profits and governments focus on philanthropic rare disease drug repurposing. In the future, it is likely that both groups will increase their use of drug repurposing as a means of developing treatments for rare diseases, but for different reasons.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.